HemosIL Liquid Anti-Xa- automated chromogenic assay for in vitro diagnostic use by laboratory pr...

FDA Device Recall #Z-0150-2022 — Class II — August 25, 2021

Recall Summary

Recall Number Z-0150-2022
Classification Class II — Moderate risk
Date Initiated August 25, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Instrumentation Laboratory
Location Bedford, MA
Product Type Devices
Quantity 25,738 US

Product Description

HemosIL Liquid Anti-Xa- automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay provides quantitative results on 3.2% citrated human plasma Part Number: 0020302602

Reason for Recall

Labeled On-board instrument stability issue for current and future lots, reduced On-board Instrument Stability from 7 days to 5 days

Distribution Pattern

US Nationwide Foreign: Canada Armenia Austria Australia Belgium Brunei Brazil Belarus Switzerland China Colombia Czech Republic Germany Denmark Spain Finland France United Kingdom Gibraltar Greece Hong Kong Hungary Indonesia Ireland Israel India Iran Italy¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿ Japan South Korea Kuwait Kazakhstan Lebanon Sri Lanka Lithuania Luxembourg Macau Mexico Malaysia Netherlands Poland Portugal Qatar Reunion Romania Serbia Russia Saudi Arabia Sweden Thailand Tunisia Turkey Taiwan Vietnam Zambia

Lot / Code Information

All currently released lots and future lots

Other Recalls from Instrumentation Laboratory

Recall # Classification Product Date
Z-1538-2026 Class II GEM Premier 5000; Part No. 00055430008. Jan 20, 2026
Z-1528-2026 Class II GEM Premier 5000 PAK; Part No. 00055407504. Jan 20, 2026
Z-1524-2026 Class II GEM Premier 5000 PAK, Part No. 00055360004. Jan 20, 2026
Z-1533-2026 Class II GEM Premier 5000; Part No. 00055415005. Jan 20, 2026
Z-1534-2026 Class II GEM Premier 5000; Part No. 00055415008. Jan 20, 2026

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.